Most antipsychotic agents utilized in the treatment of schizophrenia, bipolar disorder, and other psychoses are dopaminergic antagonists that interact with the renin–angiotensin–aldosterone system, hence disrupting the regulation of BP [76]. The gene discussed is REN; the disease is bipolar disorder.